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Abstract
Background: Present study was designed to establish a causal connection between changes in the cell-cell
junction protein expression at the blood-testis barrier and alterations in the adult rat testis histology following an
anti-androgen flutamide exposure. Particular emphasis was placed on the basal ectoplasmic specialization (ES) in
the seminiferous epithelium and expression of gap junction protein, connexin 43 (Cx43).
Methods: Flutamide (50 mg/kg body weight) was administered to male rats daily from 82 to 88 postnatal day.
Testes from 90-day-old control and flutamide-exposed rats were used for all analyses. Testis morphology was
analyzed using light and electron microscopy. Gene and protein expressions were analyzed by real-time RT-PCR
and Western blotting, respectively, protein distribution by immunohistochemistry, and steroid hormone
concentrations by radioimmunoassay.
Results: Seminiferous epithelium of both groups of rats displayed normal histology without any loss of germ cells.
In accord, no difference in the apoptosis and proliferation level was found between control and treated groups. As
shown by examination of semi-thin and ultrathin sections, cell surface occupied by the basal ES connecting
neighboring Sertoli cells and the number of gap and tight junctions coexisting with the basal ES were apparently
reduced in flutamide-treated rats. Moreover, the appearance of unconventional circular ES suggests enhanced
internalization and degradation of the basal ES. These changes were accompanied by decreased Cx43 and ZO-1
expression (p < 0.01) and a loss of linear distribution of these proteins at the region of the blood-testis barrier. On
the other hand, Cx43 expression in the interstitial tissue of flutamide-treated rats increased (p < 0.01), which could
be associated with Leydig cell hypertrophy. Concomitantly, both intratesticular testosterone and estradiol
concentrations were elevated (p < 0.01), but testosterone to estradiol ratio decreased significantly (p < 0.05) in
flutamide-treated rats compared to the controls.
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Conclusions: Short-term treatment with flutamide applied to adult rats exerts its primary effect on the basal ES,
coexisting junctional complexes and their constituent proteins Cx43 and ZO-1, without any apparent morphological
alterations in the seminiferous epithelium. In the interstitial compartment, however, short-term exposure leads to
both histological and functional changes of the Leydig cells.
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Background
In the testis, Sertoli cells serve as supporting cells and
reside as a basal epithelial lining within the seminiferous
epithelium. They create a specialized microenvironment
to support the germ cell development especially through
the formation of the blood-testis barrier (BTB). The
BTB is different from most other tissue barriers; its
structural components include not only tight junctions
(TJs), but also gap junctions (GJs) and atypical adherens
junctional complexes - ectoplasmic specialization (ES)
[1, 2]. The basal ES is found between adjacent Sertoli
cells and their projections at the BTB, while the apical
ES is limited to the interface between the Sertoli cell and
elongating spermatids [3, 4].
Several lines of evidence indicate that not only TJ but
also GJ are required for adequate functioning of the
testis. In adult male, connexin 43 (Cx43), the most abun-
dant testicular GJ protein is predominantly localized at
the region of BTB and among Leydig cells within the
interstitial tissue [5, 6]. Studies on Sertoli cell-specific
deletion of Cx43 revealed that this connexin is an abso-
lute requirement for the Sertoli cell development and
initiation of spermatogenesis [7, 8]. Several studies on
human, rodents [9, 10], and non-rodent species such as
stallion, European bison, and pig [11–13] have docu-
mented alterations in Cx43 expression in seminiferous
tubules as associated with impaired spermatogenesis.
Testosterone is essential for male fertility, mediating
its biological effects through the androgen receptor (AR)
present in somatic Leydig, peritubular, and Sertoli cells.
It has been shown that testosterone is a direct regulator
of BTB function and dynamics [14]. Strong evidence for
an important role of testosterone acting via AR for the
maintenance of BTB integrity was provided by the stud-
ies of Sertoli-cell specific AR knockout (SCARKO) mice
[15]. Since unbalanced ratio of the active androgens can
lead to various structural and functional abnormalities
within the testes, analyses of the effects of environmental
or chemical compounds antagonizing physiological an-
drogen action are of potential importance [16, 17].
Flutamide, a pharmaceutical non-steroidal anti-androgen
discovered as a treatment for androgen-dependent prostate
cancer, acts as a competitive antagonist that inhibits the ef-
fects of androgens through AR blockade [18]. Thus in
experimental studies, flutamide is often used to study the
role of androgen receptor signaling in physiological and
pathological processes. Taking into account our previous
studies showing affected spermatogenesis in boars treated
with flutamide neonatally [13, 19] and recent observations
showing altered immunoexpression of Cx43 at the BTB
level after flutamide exposure of adult rat [20] and in pri-
mary rat Sertoli cells in vitro [21], we hypothesize that lim-
ited exposure to flutamide may have a direct impact on the
Cx43 gene expression in the testis, which may precede an
impact on the tissue histology. To assess this we ap-
plied short, seven-day-treatment with flutamide and
examined rat seminiferous tubule morphology and
Cx43 expression at the mRNA and protein level. The
effects of flutamide on apoptosis and proliferation of
testicular cells were also investigated. To get a deeper
insight into the action of flutamide on the morph-
ology of the BTB, we studied the organization of the
basal ES and intercellular junctions residing in this
region at the ultrastructural level. Since within the
BTB, the tight and gap junctions are located next to
each other, we finally examined the expression of the
tight junction-associated protein, zonula occludens-1
(ZO-1). Elucidation of a causal connection between
changes in the Cx43 and ZO-1 expression within the
tubule and alterations in the seminiferous epithelium
morphology may be of importance for understanding
and predicting fertility disorders induced by anti-
androgens.
Methods
Animals and experimental design
Eighty-two-day old male Wistar rats (Rattus norvegicus)
(~300 g b. w.) originating from five litters were allotted
into experimental (n = 6) and control (n = 6) groups. Rats
were kept in the animal house of the Institute of Zo-
ology, Jagiellonian University in Krakow in a controlled
environment with a temperature of 22 ± 2 °C at 55 ± 5 %
humidity and a 12-h light/dark cycle. Standard pellet
food (Motycz, Poland) and tap water were available ad
libitum. Experimental rats were injected subcutaneously
with 50 mg⁄ kg b.w. of flutamide (2-methyl-N-[4-nitro-3-
(trifluoromethyl)-phenyl]propamide; Sigma–Aldrich, St.
Louis, MO, USA, suspended in corn oil) daily for seven
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consecutive days (82 – 88 day of postnatal life). Rats
from the control group were given corn oil only. Ani-
mals were maintained until 90 days of age when the tes-
tes were removed.
According to our hypothesis, to discriminate a primary
effect of androgen signaling disruption by flutamide, it
was important to select a dose, frequency, and time of
flutamide treatment which was high enough to induce
changes in the expression of intercellular junction pro-
teins within seminiferous epithelium without causing al-
terations in testicular cell morphology and producing a
toxic effect in Sertoli cells in vitro. Thus treatment
protocol was based on the literature data and our previ-
ous studies [20–22].
The use of animals reported herein was approved by the
First Local Ethical Committee on Animal Testing at the
Jagiellonian University in Krakow (approval No. 116/2012).
Tissue preparation
Both testes of each individual of control and flutamide-
treated rats were surgically removed and cut into small
fragments. For histology and immunohistochemistry,
tissue samples were fixed in 4 % formaldehyde freshly
prepared from paraformaldehyde and embedded in para-
plast. Other tissue fragments were immediately frozen in
a liquid nitrogen and stored at −80 °C for RNA isolation,
protein extraction, and determination of hormone levels
in testes homogenates.
Morphology
For routine histology, hematoxylin-eosin (H-E) staining
was performed. The sections were examined under
Nikon Eclipse Ni-U microscope (Nikon, Tokyo, Japan).
A tubus setting of 1.25, a × 10 ocular, and a × 10 object-
ive were used for the measurements. Detailed morpho-
logic analysis was performed with the use of NIS-
Elements software (Nikon, Tokyo, Japan), as previously
described [23]. Diameter of 50 seminiferous tubules pro-
files that were round or nearly round were measured,
and a mean was determined for control and treatment
groups. The area of the interstitium occupied by Leydig
cells was determined in 40 random fields of vision
(which corresponds to 17.7 mm2) for each animal from
control and treated groups. Then, Leydig cells were
counted, and the mean number of the cells per 1 mm2
of the interstitial tissue was determined for each section.
Electron microscopy (EM) studies
The fixation procedure described below was based on
the protocols proposed by Russell [24, 25]. The modifi-
cation developed in our labs had important advantages:
it improved the quality of fixation and enhanced the
contrast of plasma membranes, allowing observation of
ectoplasmic specializations even at the level of light
microscopy. Briefly, dissected testes of control and
flutamide-treated rats were immersed in ice-cold pre-
fixative containing 2 % formaldehyde and 2.5 % glutaral-
dehyde in 0.1 M phosphate buffer, pH 7.3. Then individ-
ual seminiferous tubules were isolated and fixed in the
same fixative for 2 h at 4 °C. The tubules were then
rinsed and post-fixed in a mixture of 2 % osmium tet-
roxide and 0.8 % potassium ferrocyanide in the same
buffer for 30 min at 4 °C. The material was embedded in
Glycid Ether 100 resin (Serva, Heidelberg, Germany).
Semi-thin sections (0.7 μm thick) were stained with 1 %
methylene blue and examined under a Leica DMR (Wet-
zlar, Germany) microscope. Prior to embedding small
(3–5 mm) pieces of seminiferous tubules were carefully
oriented in the mold to obtain accurate cross sections of
the tubules. Ultrathin sections (80 nm thick) were con-
trasted with uranyl acetate and lead citrate and analyzed
with a JEOL 2100 HT (Japan) TEM.
TUNEL assay
The presence of apoptosis-related DNA strand breaks in
testicular cells was evaluated by TUNEL assay using the
In situ Cell Death Detection kit, POD (Roche, Mann-
heim, Germany) according to the manufacturer’s in-
structions. Apoptotic cells were observed under bright
field optics in Leica DMR microscope (Leica Microsys-
tems, Wetzlar, Germany) using a 40 × objective, and
scored by an observer blinded to the treatment groups.
For each testicular cross section, all cross-sectional
tubular profiles (∼100) were counted and the number of
TUNEL-positive cells noted for each cross-sectioned
tubule.
Immunohistochemistry: qualitative and quantitative
evaluation
To optimize immunohistochemical staining the sections
were immersed in 10 mM citrate buffer (pH 6.0) and
heated in a microwave oven (2 × 5 min, 700 W). There-
after, sections were immersed sequentially in H2O2 (3 %;
v/v) for 10 min and normal goat serum (5 %; v/v) for
30 min which were used as blocking solutions. After over-
night incubation with rabbit polyclonal antibody against
Cx43 (1: 2000; Sigma-Aldrich, St Louis, MO, USA) or
mouse monoclonal antibody against ZO-1 (1 : 500; Invi-
trogen) at 4 °C, biotinylated antibodies (goat anti-rabbit
and anti-mouse IgGs; 1: 400; Vector, Burlingame CA,
USA) and avidin-biotinylated horseradish peroxidase
complex (ABC/HRP; 1:100; Dako, Glostrup, Denmark)
were applied in succession. Bound antibody was visualized
with 3,3’-diaminobenzidine (0.05 %; v/v; Sigma-Aldrich) as
a chromogenic substrate. Control sections included omis-
sion of primary antibody and substitution by irrelevant
IgG. The whole procedure was described in detail else-
where [13, 19]. Experiments were repeated three times.
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The sections were examined with a Leica DMR micro-
scope (Wetzlar, Germany). To evaluate the intensity of
immunohistochemical reaction quantitatively, digital im-
ages were obtained and analyzed using a public domain
ImageJ software (National Institutes of Health, Bethesda,
Maryland, USA). The intensity of the immunostaining was
calculated using the formula described by Smolen [26]
and expressed as relative optical density (ROD) of diami-
nobenzidine brown reaction products. A total number of
20 testis sections (n = 10 per group) were subjected to
image analysis and results of 10 separate measurements
were expressed as mean ± SD.
Western blot analysis
Lysates were obtained by sample homogenization and
sonication with a cold Tris/EDTA buffer (50 mM Tris,
1 mM EDTA, pH 7.5), supplemented with a broad-
spectrum protease inhibitors (Sigma-Aldrich). The pro-
tein concentration was estimated by the Bio-Rad DC
Protein Assay Kit with BSA as a standard (Bio-Rad Labs,
GmbH, München, Germany). Equal amounts of protein
were resolved by SDS-PAGE under reducing conditions,
transferred to polyvinylidene difluoride membranes
(Merck Millipore, Darmstadt, Germany) and analyzed by
Western blotting with: rabbit polyclonal antibodies
against Cx43 (1 : 12 000; Sigma-Aldrich) or caspase 3 (1
: 1000; Cell Signaling Technology, Beverly, MA, USA),
or mouse monoclonal antibodies against ZO-1 (1 : 500;
Invitrogen) or PCNA (1 : 500; Merck Millipore), as pre-
viously reported [19]. The presence of the primary anti-
body was revealed with horseradish peroxidase-
conjugated secondary antibodies diluted 1:3000 (Vector
Lab., Burlingame, CA, USA) and visualized with an en-
hanced chemiluminescence detection system as previ-
ously described [20]. Actin served as a loading control.
To obtain quantitative results the bands (representing
each data point) were densitometrically scanned using
the public domain ImageJ software (National Institute of
Health, Bethesda, MD, USA) and the data obtained for
each protein were normalized against its corresponding
β-actin. Protein level within the control group was arbi-
trarily set as 1.
RNA Isolation, Reverse Transcription
Total RNA was extracted from testes using TRIzol® re-
agent (Life Technologies, Gaithersburg, MD, USA) ac-
cording to the manufacturer’s instructions. To remove
contaminating DNA and DNase from RNA preparations,
the RNA samples were incubated with reagents from the
TURBO DNA-free™ Kit (Ambion, Austin, TX). The yield
and quality of the RNA were assessed using a NanoDrop
ND2000 Spectrophotometer (Thermo Scientific, Wil-
mington, DE, USA) and by electrophoresis. Total cDNA
was prepared using High-Capacity cDNA Reverse
Transcription Kit (Applied Biosystems, Carlsbad, CA,
USA) according to the manufacturer’s instructions.
Real-Time Quantitative RT-PCR
Real-time RT-PCR was performed using the StepOne
Real-Time PCR system (Applied Biosystems) and opti-
mized standard conditions as described previously [20].
The mRNA expression levels of the Cx43 and ZO-1 were
quantified in each sample using TaqMan Gene Expression
Assays (Applied Biosystems) as follows: for Cx43 assay ID,
Rn01433957_m1; for ZO-1 assay ID, Rn02116071_s1;
GAPDH levels were determined as an endogenous control
assay (Applied Biosystems, assay ID, Rn01775763_g1).
Control reactions either without the RNA template or
without the reverse transcriptase enzyme were performed.
Relative quantification (RQ) was obtained using the
2 −ΔΔCt method, adjusting the Cx43 and ZO-1 mRNAs
expression to the expression of GAPDH mRNA and tak-
ing the adjusted expression in the control group as refer-
ence (RQ = 1) [27]. Three independent experiments were
performed, each in triplicate with tissues prepared from
different animals. All PCR products stained with Midori
Green Stain (Nippon Genetics Europe GmbH, Düren,
Germany) were run on 2.5 % agarose gels. Images were
captured using a Bio–Rad Gel Doc XR System (Bio–Rad
Laboratories, Hercules, CA, USA).
Radioimmunological analysis
Homogenized testicular tissues from control and
flutamide-treated rats were used for radioimmunological
determination of testosterone and estradiol levels as de-
scribed previously [28]. Testosterone levels were
assessed using [1,2,6,7-3H]-testosterone (The Radio-
chemical Centre, Nycomed Amersham, Buckingham-
shire, England), specific activity 88.0 Ci/mmol, as a
tracer and antibody raised in rabbit against testosterone-
3-(O-carboxymethyl) oxime-bovine serum albumin
(BSA), whereas estradiol concentrations were deter-
mined using [2,4,6,7-3H]-estradiol (The Radiochemical
Centre, Nycomed Amersham), specific activity 140 Ci/
mmol, as a tracer and an antibody raised in rabbit
against 17β-estradiol-6-(O-carboxymethyl) oxime-BSA.
The within-assay coefficients of variation were < 8 %. All
samples were assayed in duplicates from at least three
separate experiments.
Statistical analysis
Each variable was tested by using the Shapiro-Wilk W-
test for normality. Homogeneity of variance was assessed
with Levene’s test. Since the distribution of the variables
was normal and the values were homogeneous in vari-
ance, all statistical analyses were performed using one-
way analysis of variance (ANOVA) followed by Tukey’s
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post hoc comparison test to determine which values dif-
fered significantly from controls. The analysis was made
using Statistica software (StatSoft, Tulsa, OK, USA).
Data were presented as mean ± SD. Data were consid-
ered statistically significant at p < 0.05.
Results
Effect of flutamide on testis morphology
Spermatogonia, spermatocytes and haploid germ cells at
advanced stages of differentiation (round and elongated
spermatids) were observed in testes of control and
flutamide-treated rats (Fig. 1a, a’ , b, b’). Both Sertoli and
germ cells displayed normal morphology without any
loss of germ cells irrespective of the group of rats. As
shown on semi-thin sections, numerous ESs were ob-
served in the control (Fig. 1a’), whereas flutamide treat-
ment led to apparent reduction of the cell surface
occupied by the basal ES connecting neighboring Sertoli
cells and/or their projections (Fig. 1b’ , for details see
also the section below). On the other hand, the intersti-
tial area containing Leydig cells was enlarged after fluta-
mide exposure (Fig. 1b). To analyze the effect of
flutamide exposure quantitatively, seminiferous tubule
diameter and area occupied by Leydig cells were mea-
sured, and the number of Leydig cells per unit area was
counted. Seminiferous tubule diameter did not change,
whereas the area occupied by Leydig cells increased sig-
nificantly in flutamide-treated rats compared to the con-
trol. The number of Leydig cells per unit area of
interstitial tissue was almost 2-fold reduced after fluta-
mide exposure (Table 1).
Effect of flutamide on the ultrastructure of the basal ES
Analysis of serial semi-thin sections (compare Fig. 1a’
and b’) and ultra-thin sections showed that flutamide
treatment led to the reduction of the cell surface occu-
pied by the basal ES connecting adjoined Sertoli cells
(compare Fig. 2a, b and d). Moreover, our analyses re-
vealed that the number of 3-membrane junctions was
much lower within the basal ES of flutamide-treated rats
(Fig. 2d) when compared with the control ones (Fig. 2a,
b). Above observations indicated that the number of cell
projections interdigitated between adjacent Sertoli cells
was distinctly reduced in flutamide-treated rats. This, in
turn, coincided well with the observation of unconven-
tional circular ES (Fig. 2e) observed in the neighborhood
of the Sertoli cell surface of experimental animals. Such
circular “segments” of the basal ES were most probably
formed as a result of retraction of Sertoli cell projections
and/or internalization of the junctional complexes by
the Sertoli cell cytoplasm. It should be noted here that
morphologically similar circular ES were never noted in
the testes of control rats. The EM analyses also showed
that the number of gap and tight junctions coexisting
with the basal ES or located in their vicinity was reduced
in treated rats, compared with the controls (compare
Figs. 2d and a, b). Similar reduction was also observed in
case of the circular ES that, as a rule, contained only sin-
gle or few TJs (Fig. 2e).
In our fixation procedure potassium ferrocyanide
(contained in the post-fixative) contrasted only “open”
intercellular spaces, it did not penetrate between mem-
branes sealed by tight junctions. Thus the procedure
allowed also “visualization” of functional state of the
basal ES, i.e. the permeability of the TJs located within
the ES. In control rats the electron-dense tracer freely
penetrated between non-specialized membranes (Fig. 2a-
c) and was stopped at the basal limit (border) of the ES
(Fig. 2b). In rats treated with flutamide, at least some
junctional complexes (ES and coexisting TJs) were per-
meable and penetrated by the tracer (Fig. 2f ).
Effect of flutamide on apoptosis and proliferation in adult
testis
To investigate the effect of androgen signaling disrup-
tion on apoptosis and proliferation in testes of
flutamide-treated and control rats, in situ TUNEL assay
and cleaved caspase 3 as an apoptotic marker, and prolif-
erating cell nuclear antigen (PCNA) as a proliferation
marker, were used, respectively (Fig. 1c-f ).
TUNEL-labeled cells were rarely observed in the sem-
iniferous epithelium of flutamide-treated and control
rats (Fig. 1c). Apoptotic cells were mostly accounted for
as spermatocytes. Nuclear staining pattern permitted to
score apoptotic cell number, although no significant
changes in TUNEL-positive cells frequency were ob-
served after flutamide exposure compared with the con-
trol (Fig. 1d).
Using Western blot both procaspase 3 and cleaved
caspase 3 were detected in testis homogenates of
flutamide-treated and control rats (Fig. 1e). Densitomet-
ric analysis revealed no statistically significant differences
between the level of cleaved caspase-3 in testes of
flutamide-treated and control rats (Fig. 1e).
The expression of PCNA was also analyzed by Western
blotting. Treatment with flutamide resulted in a slight, no
statistically significant increase in the PCNA level (Fig. 1f).
Effect of flutamide on the expression of mRNA and
protein for Cx43 and its immunolocalization in adult
testis
To assess the effect of flutamide on Cx43 expression at
mRNA and protein levels, RT-PCR and Western blot
analysis were performed, respectively. Electrophoresis
revealed PCR-amplified products of the predicted sizes;
87 bp for Cx43 and 175 bp for GAPDH in testes from
flutamide-treated and control rats (Fig. 3a). Real-time
RT-PCR revealed an up-regulation of Cx43 mRNA
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expression (p < 0.05) in flutamide-exposed rat testes
(Fig. 3b). For negative controls, RT or cDNA was omit-
ted from each reaction.
Western blot analysis revealed immunodetectable
Cx43 as a single protein band near 43 kDa position of
the gel, in testicular homogenates of flutamide-treated
Fig. 1 a-f Testis morphology (a-b), apoptosis (c-d) and proliferation (e-f) in control and flutamide-treated rats. a-b Morphology of the testis.
Representative section of control (a) and flutamide-treated (b) rats. H-E staining. Scale bars represent 15 μm. Note full spermatogenesis in
seminiferous tubules (ST) of both control and flutamide-treated testes (a-b) and enlarged interstitial tissue (IT) after flutamide exposure (b).
Representative semi-thin section of control (a’) and flutamide-treated rats (b’). Scale bars represent 15 μm. Both cross-sections (a’, b’) illustrate
different cell types present during spermatogenesis. From the basal membrane to the lumen: spermatogonia (sg), spermatocytes (sp), round
spermatids (r.s) and elongated spermatids (e.s) are visible. Sertoli cell (Sc) nucleus is situated close to the basal membrane, while Sertoli cell
cytoplasm extends towards the lumen being in close contact with the other cell types. Note any loss of germ cells within the seminiferous
epithelium (a’, b’). Abundant distribution of ectoplasmic specializations (arrows) close to the basal membrane of control testis (a’). Note the
reduction of the cell surface occupied by the basal ectoplasmic specializations connecting adjoined Sertoli cells (arrow) following flutamide
treatment (b’). C-F. TUNEL staining, caspase 3 protein, and proliferating nuclear antigen (PCNA) expression in testes of control and flutamide-
treated rats. Representative TUNEL staining (arrow, c). Scale bars represent 15 μm. Immunoreactive cells were absent in negative control sections
(c, top). Quantitative analysis of TUNEL-positive cells (d). Representative immunoblots for caspase 3 (e, top) and PCNA (f, top). The band at 32 kDa
represents inactive proenzyme (procaspase 3) and the band at 17 kDa corresponds to active form (cleaved caspase 3). Actin was used as a
loading control, and each set of shown actin immunoblots corresponds to the target protein that was investigated within a given panel. The
relative level of cleaved caspase 3 (e, bottom) and PCNA (f, bottom) protein normalized against its corresponding β-actin. Data obtained from
three separate analyses is expressed as mean ± SD. Control (n = 6) and flutamide (n = 6) group
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Fig. 2 a-f Ultrastructure of basal ectoplasmic specialization in control (a-c) and flutamide-treated (d-f) rats. a-c Basal ectoplasmic specialization
connecting adjoined Sertoli cells in control rats. Note that electron-dense tracer penetrates only between non-specialized membranes (double
arrows in a, b, and c) and is stopped at the basal limit of ectoplasmic specialization (asterisk in b). Tangential section through the junctional
complex (sandwiched between endoplasmic reticulum cisternae) located next to non-specialized membranes (c). Scale bars represent 0.5 μm.
d-f Basal ectoplasmic specialization in flutamide-treated rat. Note loss of 3-membrane junctions (D); two circular ectoplasmic specializations in the
cytoplasm of Sertoli cell (e); junctional complex (ectoplasmic specialization + tight junctions) penetrated by the tracer (double arrows in f). Scale
bars represent 0.5 μm. Basement membrane – bm; endoplasmic reticulum – er; mitochondrium - m; Sertoli cell nucleus – nu. Arrows indicate
3-membrane junctions, open arrowheads – gap junctions, arrowheads – tight junctions
Table 1 Diameter of the seminiferous tubules, the area occupied by Leydig cells and the number of Leydig cells per unit area of
interstitial tissue in control and flutamide-exposed rats
Control Flutamide-treated
Diameter of the seminiferous tubules (μm) 287.80 ± 32.09 295.11 ± 35.98
The area occupied by Leydig cells per 40 fields of vision (mm2) 3.42 ± 0.11 5.18 ± 0.28*
The number of Leydig cells per 1 mm2 of interstitial tissue 5984.87 ± 905.91 3275.30 ± 390.41**
Data are expressed as means ± SD. Significant differences from control values are denoted as *p < 0.05 and **p < 0.05 (n = 6 animals/each group)
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and control rats (Fig. 3c, left panel). In the testes of
flutamide-treated rats, the expression level of Cx43 sig-
nificantly increased (p < 0.05) compared with the control
(Fig. 3c, right panel).
As revealed by immunohistochemistry (see Fig. 4) flu-
tamide led to the reduction of the Cx43 signal intensity
at the base of the epithelium (Fig. 4b, b’), while a positive
signal reminded almost unchanged at the apical com-
partment of the seminiferous epithelium compared with
the control (Fig. 4a, a’). Within the interstitium, however,
a very strong linear Cx43 signal on the plasma mem-
brane of Leydig cells was found as the prevalent staining
pattern (Fig. 4b”) compared with the control (Fig. 4a”).
Thorough analysis (at higher magnification) revealed a
loss of linear staining pattern at the region of the BTB
(Fig. 4b’versus a’) what was confirmed by the optical
density quantitative measurement. The signal was sig-
nificantly reduced (p < 0.01) in flutamide-treated tissue
(18.82 ± 1.15) compared with the control (39.61 ± 3.20).
Further quantitative evaluation of the Cx43 signal also
reflected the qualitative results. There was no statisti-
cally significant difference between the Cx43 signal at
the Sertoli cell-elongated spermatid interface in
flutamide-treated testis (32.38 ± 3.32) versus control one
(38.15 ± 4.65), while in hypertrophic Leydig cells of
flutamide-exposed animals the Cx43 signal was signifi-
cantly higher (p < 0.01) than that of the control (43.05 ±
3.37 versus 25.58 ± 4.86).
Effect of flutamide on ZO-1 immunolocalization and
expression of mRNA and protein for ZO-1 in adult testis
As shown by immunohistochemistry, in control rats the
ZO-1 signal appeared at the entire cell surfaces of Sertoli
cells (Fig. 5a, a’), whereas flutamide treatment resulted
in the protein delocalization; the ZO-1 staining fre-
quently dispersed in the cell cytoplasm at the base of the
epithelium (Fig. 5b, b’). The changes in the staining pat-
tern of ZO-1 were accompanied by reduction in the
staining intensity (Fig. 5b, b’ versus a, a’). Optical density
evaluation revealed significant decrease in ZO-1 immu-
noexpression (p < 0.01) between flutamide-treated and
control rats (20.23 ± 1.66 versus 32.09 ± 2.16), respect-
ively. Although immunoreactivity of ZO-1 at the BTB
was easily recognizable a mild non-specific staining
across the epithelium was also visible.
Real time RT-PCR and Western blot analyses revealed
down-regulation of both ZO-1 mRNA expression (p <
0.05) (Fig. 5c-d) and ZO-1 protein level (p < 0.05) in
flutamide-treated rats when compared with the control
(Fig. 5e-f ), respectively.
Effects of flutamide on testosterone and estradiol
concentrations in testicular homogenates
After flutamide exposure testosterone concentration
(9.38 ± 2.3 ng/mg tissue) and estradiol concentration
(19.0 ± 2.0 pg/mg tissue) significantly increased (p < 0.01)
compared with the control values (5.43 ± 2.7 ng/mg tis-
sue and 8.0 ± 1.0 pg/mg tissue, respectively), however,
testosterone to estradiol ratio significantly decreased
(497.13 ± 128.07 in flutamide-treated rats versus 759.13
± 194.25 in control rats; p < 0.05).
Discussion
Although the tight and adherens junction protein ex-
pression have been characterized as androgen-dependent
[29, 30] few data are available regarding the action of
anti-androgens on the gap junction organization and
Cx43 gene expression in adult rat testis [5]. Our results
suggest that short, postnatal exposure to flutamide may
have a primary impact on the gap junction organization
in the testis. This notion is supported by the following
observations: (i) flutamide treatment led to the several
ultrastructural alterations of the basal ES (including the
number of junctions) and changes in the Cx43 expres-
sion at the mRNA and protein level, (ii) localization of
the ZO-1 and Cx43 were also affected after flutamide
exposure, (iii) this treatment did not lead to histological
disturbance of the seminiferous epithelium, and (iv) did
Fig. 3 a-c Analyses of Cx43 gene expression in testes of control and flutamide-treated rats. Representative RT-PCR (a), quantitative real-time PCR
(b), and Western blot (c). As an internal control, the GAPDH mRNA level was measured in the samples. N1 – negative control without cDNA
template. N2 – negative control without reverse-transcribed RNA. Relative quantification (RQ) is expressed as mean ± SD. The relative level of
Cx43 protein normalized to β-actin which served as an internal protein loading control. Data obtained from three separated analysis are expressed
as mean ± SD. Significant differences from control values are denoted as *p < 0.05. Control (n = 6) and flutamide (n = 6) group
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not cause obvious changes in cell apoptosis and
proliferation.
We demonstrated up-regulation of Cx43 gene expres-
sion in testes of flutamide-treated rats with concomitant
reduction of Cx43 immunoexpression and loss of the
signal from the Sertoli cell membranes at the BTB, al-
though the Cx43 signal was almost unchanged at the
Sertoli cell-elongated spermatid interface. The question
aroused whether diminished Cx43 expression at the
BTB (as a consequence of anti-androgen exposure) may
be related to structural changes in the cell-cell junctions
seen at the ultrastructural level. As shown by electron
microscopy, cell surface occupied by the basal ES con-
necting adjoined Sertoli cells was apparently reduced,
the number of 3-membrane junctions within the basal
ES was clearly lowered (indicating a distinct reduction in
the number of cell projections interdigitating between
adjacent Sertoli cells), and the number of gap and tight
junctions coexisting with the basal ES was reduced in
flutamide-treated rats compared with the controls. We
suggest that the reduction of the surface occupied by the
basal ES is a consequence of internalization of ES seg-
ments into the Sertoli cell cytoplasm. This hypothesis is
strongly supported by the presence of unconventional
Fig. 4 a-b Immunohistochemical localization of Cx43 in testes of control (a, a’, a”) and flutamide-treated (b, b’, b”) rats. Scale bars represent
15 μm. All sections were counterstained with Mayer’s haematoxylin. In control rats (a, a’, a”) Cx43 is distributed in linear array between adjacent
Sertoli cells at the level of the BTB (arrowheads). For details, see the higher magnification in a’. Note also Cx43 signal between Sertoli cells and
spermatocytes and at the Sertoli cell-elongated spermatid interface (arrows; a, a’). In the interstitium, a strong signal for Cx43 is localized to Leydig
cells (asterisks; a, a’, a” and insert in a”). Following flutamide treatment (b, b’, b”), note apparent decrease in the Cx43 immunostaining at the BTB
site (arrowheads). For details, see the higher magnification in B’. Similar signal intensity as in control testis is visible at the Sertoli cells-elongated
spermatid interface (arrows; b, b’). Note very strong linear signal at cellular membrane between neighboring Leydig cells in the interstitium
(asterisks; b” and insert in b”). Rectangles indicate the location of the higher magnification view. No signal was detected when anti-Cx43 antibody
was substituted by normal goat serum (insert in a’)
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circular ES close to the Sertoli cell surface observed only
in flutamide-exposed rats. Morphologically similar in-
ternalization (“endocytosis”) of intercellular (gap) junc-
tions have been earlier reported by Jordan et al. [31] and
Leithe et al. [32]. The authors have also shown that in-
ternalized gap junctions (termed annular gap junctions)
form double-membrane vacuoles that integrate with
endosomes and are finally degraded by endolysosomal
proteases. We hypothesize that similar mechanism of
endosomal degradation operates also during reduction
of the basal ES surface in the system presented herein.
This issue is currently under study in this laboratory.
Moreover, we showed reduced tight junction-
associated protein (ZO-1) expression at the mRNA and
protein level after flutamide exposure. Down-regulation
of ZO-1 gene could reflect impaired functionality of the
basal epithelium since the ZO-1 delocalization from Ser-
toli cell membranes to the cell cytoplasm was evident.
This idea is strengthened by the electron microscopy re-
sults. Due to our fixation procedure the functional state
of the basal ES was visualized. In rats treated with fluta-
mide, some junctional complexes (ES and coexisting
TJs) were permeable being penetrated by the electron-
dense tracer, whereas in control rats the tracer freely
penetrated only between non-specialized membranes.
Although we do not know what is the reason of such ef-
fect, we think that it is caused by relatively mild condi-
tions of the pre-fixation.
Further, it was important to give an answer whether
the expression of ZO-1 in the seminiferous epithelium is
somehow related to the changes of the Cx43 expression
observed in flutamide-treated rats. It was established
that Cx43 physically associates with ZO-1 and ZO-1 reg-
ulates gap junction organization in cardiomyocytes and
Sertoli cell line [33, 34]. Thus, we cannot exclude the
possibility that diminished immunoexpression of Cx43
at the BTB site of flutamide-treated rats may result, at
least in part, from decreased ZO-1 expression. Indeed,
the reduction of ZO-1 signal and its delocalization from
the membrane to the cytoplasmic compartment was re-
ported as related to degradation of the Cx43 gap junc-
tion [35]. Interestingly, a role of kinase Src in the
interaction of Cx43 with ZO-1 and in the internalization
of the BTB proteins was demonstrated [33, 36, 37]. In
accord, we have recently found that flutamide-induced
disassembly of adherens junctions at the BTB is related
Fig. 5 a-e Immunohistochemical localization of ZO-1, its mRNA, and protein expression in testes of control and flutamide-treated rats. a-b
Immunohistochemical staining in testes of control (a, a’) and flutamide-treated rats (b, b’). Nomarski interference contrast. Scale bars represent 15
μm. Arrows point to ZO-1 signal at the base of the tubule (a, a’, b, b’). Moderate to strong ZO-1 signal at the level of the BTB is visible as
continuous wavy line between adjacent Sertoli cells (a, a’). Note ZO-1 signal which lines the cytoplasmic face of Sertoli cells (a, insert in a).
Following flutamide treatment weak to moderate ZO-1 signal is visible mainly in the cell cytoplasm (b, b’). Rectangles indicate the location of the
higher magnification views (a, b). No ZO-1 signal was detected when anti-ZO-1 antibody was substituted by normal goat serum (a”). Representative
RT-PCR (C) and quantitative real-time PCR (D) analyses of ZO-1 mRNA expression in testes of control and flutamide-treated males. As an internal
control, the GAPDH mRNA level was measured in the samples (c). Lane N1 – negative control without cDNA template, lane N2 – negative control
without reverse-transcribed RNA. The relative amount of ZO-1 transcript levels (d). Relative quantification (RQ) is expressed as mean ± SD. Significant
difference from control values is denoted as *p < 0.05. Control (n = 6) and flutamide (n = 6) group. Representative Western blot analysis of ZO-1 protein
expression levels in testes of control and flutamide-treated males (e). The relative level of ZO-1 protein normalized to β-actin which served as an
internal protein loading control. Data obtained from three separate analyses are expressed as mean ± SD. Significant difference from control values is
denoted as *p < 0.05. Control (n = 6) and flutamide (n = 6) group
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to altered Src distribution at this region [20]. We suggest,
therefore, that in flutamide-exposed rats delocalization of
Cx43 and ZO-1 at the basal ES might be associated with
changes in Src functioning.
Of note, we did not find any morphological alterations
in the seminiferous epithelium and any obvious changes
in cell apoptosis and proliferation after flutamide
treatment. In agreement, Woolveridge et al. [38] demon-
strated that apoptosis and expression of apoptosis-
related proteins were unchanged following short-time
androgen signaling disruption. Also Okahara et al. [39]
provided evidence that in seminiferous tubules of rats
treated for 2 weeks with flutamide at a dose 60 mg/kg/
bw no degeneration or decrease of germ cells was ob-
served. On the other hand, increased germ cell apoptosis
and histological lesions in seminiferous epithelium were
detected in several androgen withdrawal and AR inhib-
ition models, in which androgen depletion lasted for
relatively long period [40, 41].
Our morphometric analysis, however, demonstrated
significant enlargement of the interstitial tissue with
concomitant reduction of Leydig cell number per unit
area after flutamide exposure. Since cell proliferation
and apoptosis were unaffected, this phenomenon could
be attributed to Leydig cell hypertrophy rather than
hyperplasia. The Leydig cell hypertrophy was also de-
tected in adult boars exposed to flutamide during neo-
natal period [23]. In contrary, the study by Okahara et
al. [39] based only on qualitative morphological examin-
ation (H-E staining), reported increased Leydig cell pro-
liferation after flutamide exposure. To evaluate the
function of Leydig cells in flutamide-treated rats, testos-
terone and estradiol concentrations were measured in
testes homogenates. Besides increased concentrations of
both steroids, possibly associated with interstitial tissue
enlargement, we found significant reduction of testoster-
one : estradiol ratio in flutamide-treated males compared
to the controls. The latter observation may indicate en-
hanced androgen aromatization in testes of experimental
animals, and adds to the explanation of morphological
changes in the interstitium. Indeed, previous studies
showed that excess of testicular estrogen, due to disrup-
tion of estrogen sulfotransferase gene, is associated with
Leydig cell hypertrophy [42]. On the basis of the latest
findings by O’Hara et al. [43] who generated model of
Leydig cell AR knockout mice exhibiting Leydig cell
hypertrophy and altered steroidogenesis, we propose
that structural and functional abnormalities of the inter-
stitial tissue in flutamide-exposed rats may result, at
least in part, from impaired autocrine Leydig cell AR
signaling.
Interestingly, in the apparently enlarged interstitial tis-
sue, the Cx43 signal was very strong. The abundant dis-
tribution of Cx43 immunoreactive protein at the Leydig
cell membranes suggests a potential involvement of
Cx43 in the steroidogenic function of Leydig cells. It is
likely that coordination of secretory activity among
neighbouring cells within the interstitial area may be en-
sured by gap junction functioning, as previously pro-
posed by Meda [44] for endocrine pancreas cells. It
should be added that in our studies the Cx43 expression
has been detected in homogenates of whole testes,
therefore, up-regulation of Cx43 gene expression in
flutamide-treated testes might be explained by a massive
accumulation of the protein within enlarged Leydig cell
clusters. Moreover, we earlier demonstrated that en-
hanced Cx43 immunoexpression was accompanied by
increased level of aromatase in hypertrophic Leydig cells
of Klinefelter patient [45]. Thus, an increase in Cx43 ex-
pression level in the Leydig cells of flutamide-treated
rats may result from intratesticular steroid hormones’
imbalance. Why androgen withdrawal (after flutamide
exposure) induces different effects on the Cx43 protein
expression in various cellular targets remains unclear. It
seems possible that various seminiferous tubule com-
partments and the interstitial tissue are not equally sen-
sitive to androgens and diverse signaling pathways are
modulated by the same anti-androgen in different cell
types. As we have recently demonstrated, Akt kinase-
dependent pathway activation is involved in the reduc-
tion of Cx43 protein level in rat Sertoli cells in vitro
exposed to hydroxyflutamide, an active metabolite of
flutamide [21].
Conclusions
The results reported herein are the first data demon-
strating that short treatment with flutamide affects the
level of Cx43 mRNA and protein expression, but has no
effect on testicular cell proliferation, apoptosis, and the
seminiferous epithelium histology. Altered distribution
of Cx43 and ZO-1 at the BTB region and altered expres-
sion of both proteins suggest that coexisting junctional
complexes and their proteins are primary targets for flu-
tamide action. We show also that flutamide exerts its
primary effect on the morphology of the basal ES with-
out any apparent histological alterations of the semin-
iferous epithelium. On the other hand, flutamide action
on Leydig cells is manifested by both structural and
functional changes in the interstitial compartment, in-
volving altered steroidogenic activity and increased Cx43
expression. These observations suggest diverse mecha-
nisms of flutamide action in different cellular targets
within the testis of adult rat.
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